Less frequent Pap smears appear safe for low-risk women

Article

Reducing the frequency of Papanicolaou smears from annually to once every 3 years in low-risk women places only about three per 100,000 more women between the ages of 30 and 64 at risk of cervical cancer, according to a recently published study.

Researchers from California included over 31,000 racially, ethnically, and geographically diverse women who had three or more consecutive negative annual Pap tests. They calculated that avoidance of one additional case of cervical cancer by screening 100,000 women annually for 3 years rather than once in 3 years after the last negative test would require about 69,665 additional Pap smears and 3,861 colposcopies in women 30 to 44 years of age and about 209,324 additional Pap smears and 11,502 colposcopies in women 45 to 59 years of age.

The researchers encourage practitioners and their patients to consider the small increase in risk associated with less frequent screening in comparison to the costs and stress associated with more frequent screening.

Sawaya GF, McConnell KJ, Kulasingam SL, et al. Risk of cervical cancer associated with extending the interval between cervical cancer screenings. N Engl J Med. 2003;349:1501-1509.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.